ASCO, NCCN release guidelines on managing immunotherapy toxicity – Healio
PR Newswire (press release) |
ASCO, NCCN release guidelines on managing immunotherapy toxicity
Healio “Despite the often-durable clinical benefits of the immune checkpoint blockade therapy, [immune checkpoint inhibitor] use is associated with a spectrum of adverse effects related to the mechanism of action that is quite different from other systemic … Leading Cancer Organizations Provide Guidance on Understanding and Managing Immunotherapy Side Effects Breaking: ASCO, NCCN Release Clinical Guidelines for Managing Immunotherapy-Related Toxicities |
